Gå direkt till textinnehållet

Karolinska Institutet, St. Erik Eye Hospital and Novo Nordisk collaborate to find a cure for age-related macular degeneration

24 August 2020

Karolinska Institutet and St. Erik Eye Hospital have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration. Novo Nordisk A/S will provide support and SEK 48 million in funding to enable a phase 1 clinical trial where new retinal cells generated from embryonic stem cells will be transplanted into patients. The aim is to develop a completely new cell therapy for this common but currently incurable eye disease.


Advanced dry AMD with geographic atrophy. The black marking shows the area of ​​cell death.

Anders Kvanta, professor at Karolinska Institutet and consultant at St. Erik Eye Hospital is responsible for the clinical study.

Read more in a press release from Karolinska Institutet
29 January 2021